Cargando…

A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings

INTRODUCTION: We investigated whether event-related potentials (ERP) collected in outpatient settings and analyzed with standardized methods can provide a sensitive and reliable measure of the cognitive deficits associated with early Alzheimer's disease (AD). METHODS: A total of 103 subjects wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cecchi, Marco, Moore, Dennis K., Sadowsky, Carl H., Solomon, Paul R., Doraiswamy, P. Murali, Smith, Charles D., Jicha, Gregory A., Budson, Andrew E., Arnold, Steven E., Fadem, Kalford C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879492/
https://www.ncbi.nlm.nih.gov/pubmed/27239520
http://dx.doi.org/10.1016/j.dadm.2015.08.004
_version_ 1782433680741892096
author Cecchi, Marco
Moore, Dennis K.
Sadowsky, Carl H.
Solomon, Paul R.
Doraiswamy, P. Murali
Smith, Charles D.
Jicha, Gregory A.
Budson, Andrew E.
Arnold, Steven E.
Fadem, Kalford C.
author_facet Cecchi, Marco
Moore, Dennis K.
Sadowsky, Carl H.
Solomon, Paul R.
Doraiswamy, P. Murali
Smith, Charles D.
Jicha, Gregory A.
Budson, Andrew E.
Arnold, Steven E.
Fadem, Kalford C.
author_sort Cecchi, Marco
collection PubMed
description INTRODUCTION: We investigated whether event-related potentials (ERP) collected in outpatient settings and analyzed with standardized methods can provide a sensitive and reliable measure of the cognitive deficits associated with early Alzheimer's disease (AD). METHODS: A total of 103 subjects with probable mild AD and 101 healthy controls were recruited at seven clinical study sites. Subjects were tested using an auditory oddball ERP paradigm. RESULTS: Subjects with mild AD showed lower amplitude and increased latency for ERP features associated with attention, working memory, and executive function. These subjects also had decreased accuracy and longer reaction time in the target detection task associated with the ERP test. DISCUSSION: Analysis of ERP data showed significant changes in subjects with mild AD that are consistent with the cognitive deficits found in this population. The use of an integrated hardware/software system for data acquisition and automated data analysis methods make administration of ERP tests practical in outpatient settings.
format Online
Article
Text
id pubmed-4879492
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-48794922016-05-27 A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings Cecchi, Marco Moore, Dennis K. Sadowsky, Carl H. Solomon, Paul R. Doraiswamy, P. Murali Smith, Charles D. Jicha, Gregory A. Budson, Andrew E. Arnold, Steven E. Fadem, Kalford C. Alzheimers Dement (Amst) Electrophysiological Biomarkers INTRODUCTION: We investigated whether event-related potentials (ERP) collected in outpatient settings and analyzed with standardized methods can provide a sensitive and reliable measure of the cognitive deficits associated with early Alzheimer's disease (AD). METHODS: A total of 103 subjects with probable mild AD and 101 healthy controls were recruited at seven clinical study sites. Subjects were tested using an auditory oddball ERP paradigm. RESULTS: Subjects with mild AD showed lower amplitude and increased latency for ERP features associated with attention, working memory, and executive function. These subjects also had decreased accuracy and longer reaction time in the target detection task associated with the ERP test. DISCUSSION: Analysis of ERP data showed significant changes in subjects with mild AD that are consistent with the cognitive deficits found in this population. The use of an integrated hardware/software system for data acquisition and automated data analysis methods make administration of ERP tests practical in outpatient settings. Elsevier 2015-10-02 /pmc/articles/PMC4879492/ /pubmed/27239520 http://dx.doi.org/10.1016/j.dadm.2015.08.004 Text en © 2015 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Electrophysiological Biomarkers
Cecchi, Marco
Moore, Dennis K.
Sadowsky, Carl H.
Solomon, Paul R.
Doraiswamy, P. Murali
Smith, Charles D.
Jicha, Gregory A.
Budson, Andrew E.
Arnold, Steven E.
Fadem, Kalford C.
A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings
title A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings
title_full A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings
title_fullStr A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings
title_full_unstemmed A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings
title_short A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings
title_sort clinical trial to validate event-related potential markers of alzheimer's disease in outpatient settings
topic Electrophysiological Biomarkers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879492/
https://www.ncbi.nlm.nih.gov/pubmed/27239520
http://dx.doi.org/10.1016/j.dadm.2015.08.004
work_keys_str_mv AT cecchimarco aclinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT mooredennisk aclinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT sadowskycarlh aclinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT solomonpaulr aclinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT doraiswamypmurali aclinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT smithcharlesd aclinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT jichagregorya aclinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT budsonandrewe aclinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT arnoldstevene aclinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT fademkalfordc aclinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT cecchimarco clinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT mooredennisk clinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT sadowskycarlh clinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT solomonpaulr clinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT doraiswamypmurali clinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT smithcharlesd clinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT jichagregorya clinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT budsonandrewe clinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT arnoldstevene clinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings
AT fademkalfordc clinicaltrialtovalidateeventrelatedpotentialmarkersofalzheimersdiseaseinoutpatientsettings